Stock listing

ASX:NXN Nexsen Limited Share Price

Follow Nexsen Limited into a list and get an email when it puts out news.

Share price · ASX:NXN

$0.135 AUD +0.005 (+3.8%)

Close on Nov 19, 2026

Past year -15.6% · daily closes, Nov 19, 2025 – Nov 19, 2026, adjusted for splits
Day range
$0.130 – $0.135 AUDNov 19, 2026
Volume
236,916 sharesNov 19, 2026
Market cap
$27.27M AUDAt the close on Nov 19, 2026 · price × 202.0M shares outstanding
52-week range
$0.105 – $0.345 AUDLowest and highest trades, Nov 20, 2025 – Nov 19, 2026
Traded on an average day
$23,476 AUDMedian day 68,939 shares · 7 days with no trades · last 3 months, Aug 19, 2026 – Nov 19, 2026
Nexsen Limited logo

Daily closes

Last 3 months, Aug 19, 2026 – Nov 19, 2026 · ASX:NXN · AUD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$0.135+0.005+3.8%$0.130$0.135$0.130236,916
$0.130-0.005-3.7%$0.130$0.130$0.1305,810
$0.135-0.015-10.0%$0.135$0.135$0.130204,461
$0.150-0.005-3.2%$0.155$0.155$0.15010,833
$0.155+0.005+3.3%$0.152$0.155$0.15210,000
$0.150-0.010-6.3%$0.155$0.155$0.15034,955
$0.1600.0000.0%$0.160$0.160$0.1600
$0.1600.0000.0%$0.160$0.160$0.1602,000
$0.160-0.005-3.0%$0.160$0.160$0.15044,142
$0.165+0.005+3.1%$0.160$0.165$0.16022,600
$0.1600.0000.0%$0.160$0.160$0.16013,019
$0.1600.0000.0%$0.160$0.165$0.15075,675
$0.1600.0000.0%$0.165$0.165$0.16068,939
$0.1600.0000.0%$0.165$0.165$0.16024,805
$0.160-0.010-5.9%$0.170$0.170$0.158144,389
$0.170+0.010+6.3%$0.165$0.170$0.16516,616
$0.160-0.005-3.0%$0.160$0.163$0.160132,203
$0.165+0.005+3.1%$0.165$0.165$0.16530,000
$0.1600.0000.0%$0.150$0.160$0.150141,130
$0.160+0.010+6.7%$0.160$0.160$0.1603,250
$0.150+0.020+15.4%$0.130$0.160$0.130479,177
$0.130-0.010-7.1%$0.130$0.130$0.12558,028
$0.1400.0000.0%$0.140$0.140$0.140175,783
$0.1400.0000.0%$0.140$0.140$0.1400
$0.140+0.010+7.7%$0.140$0.140$0.14035,659
$0.1300.0000.0%$0.130$0.130$0.1300
$0.130-0.005-3.7%$0.135$0.135$0.130100,000
$0.135-0.005-3.6%$0.140$0.140$0.135115,700
$0.1400.0000.0%$0.140$0.140$0.14068,555
$0.140+0.005+3.7%$0.140$0.150$0.140110,617
$0.135+0.005+3.8%$0.135$0.135$0.1353,644
$0.130-0.005-3.7%$0.130$0.140$0.130140,514
$0.135+0.010+8.0%$0.135$0.135$0.1351,292
$0.125-0.005-3.8%$0.130$0.130$0.125490,635
$0.130+0.015+13.0%$0.125$0.190$0.1251,791,287
$0.115-0.010-8.0%$0.125$0.130$0.105346,887
$0.125-0.015-10.7%$0.130$0.130$0.108662,061
$0.1400.0000.0%$0.140$0.140$0.120292,024
$0.1400.0000.0%$0.145$0.150$0.130624,627
$0.140-0.025-15.2%$0.155$0.175$0.1301,256,340
$0.1650.0000.0%$0.165$0.165$0.1650
$0.1650.0000.0%$0.165$0.165$0.1650
$0.1650.0000.0%$0.165$0.165$0.1650
$0.1650.0000.0%$0.185$0.185$0.16524,551
$0.1650.0000.0%$0.170$0.170$0.16526,104
$0.165-0.015-8.3%$0.188$0.190$0.16515,697
$0.1800.0000.0%$0.200$0.200$0.180104,603
$0.1800.0000.0%$0.185$0.185$0.17088,649
$0.180+0.005+2.9%$0.175$0.180$0.145433,128
$0.175-0.005-2.8%$0.175$0.185$0.17059,114
$0.180-0.005-2.7%$0.190$0.190$0.175156,291
$0.185+0.005+2.8%$0.180$0.200$0.175180,422
$0.1800.0000.0%$0.185$0.195$0.18034,354
$0.180-0.010-5.3%$0.205$0.205$0.18016,564
$0.1900.0000.0%$0.185$0.200$0.180116,662
$0.190-0.005-2.6%$0.200$0.200$0.180171,345
$0.195-0.015-7.1%$0.200$0.200$0.185100,011
$0.210+0.010+5.0%$0.225$0.225$0.21092,576
$0.2000.0000.0%$0.225$0.225$0.20084,964
$0.200-0.010-4.8%$0.210$0.210$0.200272,170
$0.2100.0000.0%$0.210$0.210$0.2100
$0.210-0.010-4.5%$0.230$0.230$0.21038,863
$0.220-0.020-8.3%$0.220$0.220$0.21545,385
$0.240+0.005+2.1%$0.230$0.245$0.230131,320
$0.235+0.025+11.9%$0.235$0.235$0.23515,000
$0.210-0.010-4.5%$0.215$0.215$0.210223,786
$0.220-0.020-8.3%$0.220$0.220$0.22072,706
Ticker
ASX:NXN
Asset type
Stock
Sector
Health care
Industry
Diagnostics & research services
Exchange
ASX
Currency
AUD

What changed lately

Latest news

All Nexsen Limited news

Nexsen Limited on 6ix

Sector
Health care
Industry
Diagnostics & research services
News releases
35 in the last 12 months · 37 in all · newest Nov 20, 2026 · oldest 2025
Decks
1 deck · latest Dec 8, 2025

Valuation

Price/book 4.8× against a median of 1.4×: the highest of 10 Diagnostics & research services companies shown. Statements: Year to Jun 30, 2026 · price Nov 19, 2026

Enterprise value
$22.78M AUD
P/E
Loss
EV/sales
No revenue
EV/EBITDA
Negative EBITDA
Price/book
4.8×
Gross margin
No revenue
Operating margin
No revenue
Net margin
No revenue
Debt to equity
0.0×
Beta
No index for this market yet

Diagnostics & research services: the 10 companies nearest in size, of 302 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Nexsen Limited · ASX:NXNUS$18.05MUS$15.08Mn/an/an/a4.8×n/a0.0×n/a
TFBS Bioscience, Inc. · TPEX:6939US$19.81MUS$7.83Mn/a1.3×n/a0.6×−38.6%0.0×n/a
SANIGEN Co., Ltd. · KRX:188260US$19.66MUS$10.06Mn/a2.2×n/a2.3×−82.6%0.1×n/a
NanoRepro AG · XETR:NN6US$19.45MUS$11.45Mn/an/an/a0.5×n/a0.0×n/a
Urteste S.A. · GPW:URTUS$19.24MUS$19.10Mn/a3,525×n/a3.5×n/a0.0×n/a
Genematrix Inc. · KRX:109820US$19.06MUS$6.80Mn/a0.8×31.7×1.4×−1.7%0.0×n/a
Oxford BioDynamics PLC · LSE:OBDUS$18.46MUS$20.77Mn/a14.5×n/a4.3×n/a1.3×n/a
RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makina Sanayi Ticaret A.S. · BIST:RTALBUS$18.41MUS$16.94M1.1×3.6×61.6×0.3×367.8%0.0×n/a
Genedrive PLC · LSE:GDRUS$17.85MUS$18.00Mn/a18.0×n/an/a−684.7%n/an/a
Microba Life Sciences Limited · ASX:MAPUS$17.70MUS$15.16Mn/a1.6×n/a1.1×−140.4%0.2×n/a
PlexBio Co., Ltd. · TPEX:6572US$15.79MUS$7.19Mn/a1.9×n/a1.8×−49.1%0.0×n/a
Median of the othersUS$18.76MUS$13.30M1.1×2.2×46.7×1.4×−49.1%0.0×

Team and board

Officers

OfficerRole
Amanda BurgessCompany Secretary
Sonny DiduguCompany Secretary
Mark MuzzinFounder & Managing Director
Shekhar KumtaExecutive Director

Board

DirectorRole
Reece O'ConnellNon-Executive Chairman
Grant PestellNon-Executive Director
Martina MarianoNon-Executive Director
Shekhar KumtaExecutive Director

Decks

DeckKindSlidesDate
Investor Presentation (December 2025)Investor deck15 slidesDec 8, 2025

Open Decks

Financials

Annual, in AUD

Income statement

LineFY2026
Selling, general and administrative2.87M
Operating income-6.86M
Depreciation and amortization1.46K
EBITDA-6.86M
Interest expense780.0K
Income before tax-6.55M
Net income-6.55M
Earnings per share, basic-0.03

Balance sheet

LineFY2026
Cash and equivalents4.49M
Current assets4.99M
Total assets6.70M
Accounts payable834.4K
Current liabilities1.03M
Total liabilities1.04M
Shareholders' equity5.66M
Shares outstanding200.2M

Cash flow

LineFY2026
Capital spending0
Cash from financing7.41M
Change in cash4.07M

Open Financials

Filings

FilingDateTypeFiled with
Proposed issue of securities - NXNNov 20, 2026FinancingASX
Nexsen Appointments to Advisory BoardNov 15, 2026Other filingsASX
A$1.2 million R&D Tax Incentive refund receivedNov 12, 2026ResultsASX
Results of MeetingNov 9, 2026Meeting outcomeASX
Nexsen advances kidney diagnostics programNov 5, 2026Other filingsASX
Co Secretary Appoint/Resign and Change of Registered AddressNov 2, 2026Other filingsASX
ISO 13485 Certification brings StrepSure closer to marketNov 1, 2026Operations updateASX
Quarterly Report - Q1 FY27Oct 27, 2026Quarterly reportASX
Quarterly Report - Q1 FY27Oct 27, 2026Quarterly reportASX
Notice of AGM and Meeting MaterialsOct 7, 2026Meeting noticeASX
All 37 filings
FilingDateTypeFiled with
Professor Shekhar Kumta appointed Executive DirectorSep 30, 2026Management or board changeASX
Reinstatement to QuotationSep 24, 2026Trading halt or suspensionASX
Proposed FlashDx joint venture builds on CE-marked GBS testSep 24, 2026Operations updateASX
Suspension from QuotationSep 23, 2026Trading halt or suspensionASX
Clear pathway defined to optimise StrepSureSep 23, 2026Operations updateASX
Trading HaltSep 21, 2026Trading halt or suspensionASX
Director Interest Notices re Performance RightsSep 10, 2026Ownership change noticeASX
Notification regarding unquoted securities - NXNSep 10, 2026Other filingsASX
Notification regarding unquoted securities - NXNSep 10, 2026Other filingsASX
Annual Report - FY 2026Aug 30, 2026Annual reportASX
Corporate Governance Statement and Appendix 4GAug 30, 2026Other filingsASX
Quarterly Report - Q4 FY26Jul 28, 2026Quarterly reportASX
$1.5m non-dilutive ARC funding for manufacturingJun 24, 2026FinancingASX
Nexsen secures first hospital partner in AsiaMay 12, 2026Operations updateASX
Nexsen and Universiti Malaya launch joint facilityMay 3, 2026Operations updateASX
Quarterly Report - Q3 FY26Apr 27, 2026Quarterly reportASX
QMS milestone achievedApr 6, 2026Operations updateASX
HK$6 million grant awarded to advance Asia-Pacific executionMar 30, 2026Operations updateASX
Nexsen accelerates global rollout for StrepSureMar 25, 2026Operations updateASX
FDA feedback derisks US approval pathway for StrepSureMar 22, 2026Operations updateASX
Half Yearly Report and AccountsFeb 26, 2026Interim reportASX
Quarterly Report - Q2 FY26Jan 29, 2026Quarterly reportASX
$500k govt grant expands GBS project to neonatesJan 26, 2026Operations updateASX
Investor PresentationDec 7, 2025Other filingsASX
Nexsen Appoints Global Clinical Leader to the BoardDec 2, 2025Management or board changeASX
Quarterly Report - Q1 FY26Oct 31, 2025Quarterly reportASX
Nexsen launches clinical trial for GBS Rapid SensorOct 20, 2025Operations updateASX

Open Filings

Cap table

Built by 6ix from Nexsen Limited’s releases

Common shares
201,996,200
Fully diluted
201,996,200

Fully diluted

LineShares
Common shares201,996,200

Share count over time

CountShares
Nov 22, 2026201,996,200

Open Cap table

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Amanda BurgessCompany Secretary · Since at least Nov 2, 2026
Grant PestellNon-Executive Director · Since at least Nov 17, 2026
Mark MuzzinFounder & Managing Director · Since at least Nov 17, 2026
Martina MarianoNon-Executive Director · Since at least Nov 17, 2026
Reece O'ConnellNon-Executive Chairman · Since at least Nov 17, 2026
Sanje MahasivamCTO & Research Team Leader · Nov 4, 2026 – Nov 4, 2026 · Past
Shekhar KumtaExecutive Director · Since at least Sep 30, 2026
Sonny DiduguCompany Secretary · Since at least Nov 17, 2026

Open People

Log in to ask 6ix AI your own questions about Nexsen Limited.